Gattai Minoli Agostinelli & Partners assisted, on the M&A and the management re-investment aspects, the funds managed by CVC Capital Partners in the agreement for the acquisition of a controlling stake in Recordati S.p.A. from Recordati Family.
Recordati is a global pharmaceutical group founded in Italy in 1926 and since 1984 it has been listed on the Milan Stock Exchange under the FTSE MIB index.
The completion of the transaction is subject to the receipt of antitrust clearances.
Gattai Minoli Agostinelli & Partners advised CVC with a team composed by partners Bruno Gattai, Gerardo Gabrielli, Nicola Brunetti and Lorenzo Cairo, by of counsel Prof. Marco Ventoruzzo and associates Lorenzo Fabbrini, Michele Ventura and Maria Persichetti.
In the pharmaceuticals area, Gattai, Minoli, Agostinelli & Partners had also previously assisted CVC in the acquisition of Doc Generici.